Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Kura Oncology, Inc. (KURA) had Debt to Capital Ratio of 0.02 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$20.75M |
|
$-74.12M |
|
-- |
|
$20.75M |
|
$100.75M |
|
$-80.00M |
|
$5.88M |
|
$-74.12M |
|
$-74.12M |
|
$-74.12M |
|
$-74.12M |
|
$-74.12M |
|
$-74.12M |
|
$-80.00M |
|
$-81.76M |
|
87.64M |
|
87.64M |
|
$-0.85 |
|
$-0.85 |
|
| Balance Sheet Financials | |
$620.66M |
|
$7.40M |
|
$28.72M |
|
$649.38M |
|
$121.30M |
|
$5.34M |
|
$285.54M |
|
$406.84M |
|
$242.54M |
|
$242.54M |
|
$242.54M |
|
87.02M |
|
| Cash Flow Statement Financials | |
$-181.33M |
|
$51.50M |
|
$0.66M |
|
$224.46M |
|
$95.29M |
|
$-129.18M |
|
$25.76M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.12 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.02 |
0.04 |
|
100.00% |
|
-385.53% |
|
-385.53% |
|
-- |
|
-357.19% |
|
-357.19% |
|
$-185.65M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
0.58 |
|
155.87 |
|
-30.56% |
|
-30.56% |
|
-11.41% |
|
-29.90% |
|
$2.79 |
|
$-2.12 |
|
$-2.07 |
|